AMENDED AND RESTATED SEVERANCE AGREEMENTSeverance Agreement • March 6th, 2008 • Pharmacopeia Inc • Services-commercial physical & biological research • New Jersey
This AMENDED AND RESTATED SEVERANCE AGREEMENT (the “Agreement”) is made and entered into as of the 18th day of December, 2007, by and between PHARMACOPEIA, INC., a Delaware corporation (hereinafter, the “Company”), and David M. Floyd, Ph.D., an individual (hereinafter, “Employee”).
LICENSE AGREEMENT between BRISTOL-MYERS SQUIBB COMPANY and PHARMACOPEIA, INC.License Agreement • March 6th, 2008 • Pharmacopeia Inc • Services-commercial physical & biological research • Delaware
THIS LICENSE AGREEMENT (this “Agreement”) is made and entered into as of October 11, 2007 (the “Effective Date”), by and between Bristol-Myers Squibb Company, a Delaware corporation headquartered at 345 Park Avenue, New York, New York 10154 (“BMS”), and Pharmacopeia, Inc., a Delaware corporation, having its principal office at 3000 Eastpark Boulevard, Cranbury, New Jersey 08512 (“Pharmacopeia”). BMS and Pharmacopeia are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
DISCOVERY COLLABORATION AGREEMENT between PHARMACOPEIA, INC. and BRISTOL-MYERS SQUIBB COMPANYDiscovery Collaboration Agreement • March 6th, 2008 • Pharmacopeia Inc • Services-commercial physical & biological research • Delaware
THIS DISCOVERY COLLABORATION AGREEMENT (the “Agreement”) is made and entered into effective as of October 11, 2007 (the “Effective Date”), by and between Bristol-Myers Squibb Company, a Delaware Corporation (“BMS”) and Pharmacopeia, Inc., a Delaware Corporation (“Pharmacopeia”). BMS and Pharmacopeia each may be referred to herein individually as a “Party,” or collectively as the “Parties.”
AMENDED AND RESTATED EMPLOYMENT AGREEMENT OF LESLIE JOHNSTON BROWNEEmployment Agreement • March 6th, 2008 • Pharmacopeia Inc • Services-commercial physical & biological research • New Jersey
THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into as of the 5th day of March, 2008, by and between Pharmacopeia, Inc. (hereinafter the “Company”) and Leslie Johnston Browne, Ph.D. (hereinafter “Dr. Browne”).
